Evidence map›Paper›PMID 24790804›Full record

ArticleTissue barriers2013

NFkB and Nrf2 in esophageal epithelial barrier function.

Hao Chen, Yu Fang, Wenbo Li, Roy C Orlando, Nicholas Shaheen, Xiaoxin Luke Chen

Open access · bronzeAbstract read
In one paragraph

Article in Tissue barriers, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Signaling pathways and their potential therapeutic utility in esophageal squamous cell carcinoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Changes ofOxidative medicine and cellular longevity · 2018
    Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Hao ChenCancer Research Program; JLC-BBRI; North Carolina Central University; Durham, NC USA.
Yu FangDepartment of Thoracic and Cardiovascular Surgery; The First Affiliated Hospital of Chongqing Medical University; Chongqing, China.
Wenbo LiDepartment of Gastroenterology; General Hospital of Jinan Military Command; Jinan, China.
Roy C OrlandoDivision of Gastroenterology and Hepatology; Center for Esophageal Diseases and Swallowing; Department of Medicine; University of North Carolina; Chapel Hill, NC USA.
Nicholas ShaheenDivision of Gastroenterology and Hepatology; Center for Esophageal Diseases and Swallowing; Department of Medicine; University of North Carolina; Chapel Hill, NC USA.
Xiaoxin Luke ChenCancer Research Program; JLC-BBRI; North Carolina Central University; Durham, NC USA ; Division of Gastroenterology and Hepatology; Center for Esophageal Diseases and Swallowing; Department of Medicine; University of North Carolina; Chapel Hill, NC USA.
University of North Carolina at Chapel Hill · USCommunities In Schools of Orange County · USFirst Affiliated Hospital of Chongqing Medical University · CNGeneral Hospital of Jinan Military Command · CNNorth Carolina Central University · US

Funding

Targeting the MEKK2-ERK5 Signaling Node in Triple Negative Breast CancerU54CA156735 · NCI · NORTH CAROLINA CENTRAL UNIVERSITY · PI RICHARDSON, MICHELER RICARDO · 2010 to 2021
$13.0M
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative TherapyK24DK100548 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SHAHEEN, NICHOLAS J · 2013 to 2017
$896k
NCI NIH HHS U54 CA156735NIDDK NIH HHS K24 DK100548
6 · The paper itself

Abstract

The stratified squamous epithelium of the esophagus forms a tight protective barrier. Defects of the barrier function contribute to gastroesophageal reflux disease (GERD), which is manifested as damage to the esophageal epithelium due to exposure to the gastrointestinal refluxate. In this review, we discuss the involvement of NFkB and Nrf2 in esophageal epithelial barrier function. Understanding these molecular pathways in the esophagus may help us develop therapeutic strategies to improve clinical outcomes in patients with GERD.

Indexed as

esophageal barrieresophageal epithelial barrieresophageal epitheliumGERDNFkBNrf2reflux diseasetight junction

Identifiers

PMID24790804
PMCPMC3943848
OpenAlexW1966456200

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.